Chiome Bioscience Inc. | Mutual Funds
Mutual Funds that own Chiome Bioscience Inc.
Siemens Global Growth
77,700
0.28%
2,500
0.15%
04/30/2018
GO UCITS ETF Solutions Plc - DAXglobal Gold Mining Fund
64,409
0.24%
64,409
0.09%
02/28/2018
SPDR S&P International Small Cap ETF
22,700
0.09%
0
0.01%
09/06/2018
SBI Asset Nippon Founder Equity Fund
6,299
0.02%
6,299
0.37%
06/05/2017
| Address |
Sumitomo Fudosan Nishi-Shinjuku Bldg
Tokyo Tokyo 151
Japan
|
|
Employees
|
- |
| Website |
http://www.chiome.co.jp |
| Updated |
07/08/2019 |
| Chiome Bioscience, Inc. engages in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) System. Its operations are carried out through Innovative Drug and Innovative Drug Support business segments. The Innovative Drug segment manufactures specific antibodies based on new antigen mechanisms and licenses these out to pharmaceutical industries. |
